SP600125 lipid nanoparticle preparation

We can offer a discount on bulk orders. Please contact our sales team for further inquiry.

Product Infomation

Product Name	SP600125 lipid nanoparticle preparation
Catalog Number	LNP-015
Size	10 mg; 20 mg; 50 mg
Alias	SP600125 LNP; JNK inhibitor nano-lipid nanoparticle (HZ12 prescription)
Appearance	Milky white to light yellow homogeneous suspension
Solubility	It can be dispersed in physiological buffer (such as PBS)to form a stable colloidal dispersion system
Description	SP600125 LNP is a special nano-lipid nanoparticle formulation of the JNK inhibitor SP600125, which is encapsulated using the system-optimized formula HZ12. As a broad-spectrum inhibitor of c-jun N-terminal kinase (JNK), SP600125 has important research value in pathological processes such as inflammation, neurodegenerative condition, and tumor. However, its poor water solubility, poor pharmacokinetic properties, and potential systemic tox limit the depth of its in vitro application.
Applications	Formulation development and optimization of JNK inhibitor nanodelivery system
Storage	4°C, protected from light
Purity	95%+
Shelf Life	1 Year
Shipping Condition	Low temperature transport

Online Inquiry